Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03635021
Brief Title: Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer (CR-SEQUENCE)

First Submitted : August 9, 2018
First Submitted that Met QC Criteria : August 14, 2018
First Posted : August 17, 2018

Last Update Submitted that Met QC Criteria : August 11, 2021
Last Update Posted : August 12, 2021